Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

Asian Subpopulations May Exhibit Greater Cardiovascular Benefit from Long-Acting Glucagon-Like Peptide 1 Receptor Agonists: A Meta-Analysis of Cardiovascular Outcome Trials

BackgroundBased on reported results of three large cardiovascular outcome trials (CVOTs) of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), we aimed to investigate the overall effect of GLP-1 RAs on major adverse cardiovascular events (MACEs) and to identify subpopulations exhibiting the grea...

Full description

Bibliographic Details
Main Authors: Yu Mi Kang, Yun Kyung Cho, Jiwoo Lee, Seung Eun Lee, Woo Je Lee, Joong-Yeol Park, Ye-Jee Kim, Chang Hee Jung, Michael A. Nauck
Format: Article
Language:English
Published: Korean Diabetes Association 2019-08-01
Series:Diabetes & Metabolism Journal
Subjects:
agonist
cardiovascular disease
diabetes mellitus, type 2
glucagon-like peptide 1
incretins
meta-analysis
safety
therapeutics
Online Access:http://e-dmj.org/upload/pdf/dmj-43-410.pdf

Internet

http://e-dmj.org/upload/pdf/dmj-43-410.pdf

Similar Items